Fuji Pharma Co., Ltd. announced consolidated earnings results for the nine months ended June 30, 2019. For the period, the company reported net sales of JPY 27,324 million compared to JPY 27,872 million a year ago. Operating profit was JPY 3,726 million compared to JPY 3,547 million a year ago. Ordinary profit was JPY 3,714 million compared to JPY 3,558 a year ago. Earnings per share was JPY 83.17 compared to JPY 87.10 a year ago. Profit attributable to owners of parent was JPY 2,521 million compared to JPY 2,606 million a year ago. Profit was JPY 2,521 million compared to JPY 2,607 million a year ago.

For the year ending September 30, 2019 the company expected net sales to be JPY 36,815 million. Operating profit to be JPY 4,535 million. Ordinary profit to be JPY 4,506 million. Earnings per share to be JPY 113.51. Profit attributable to owners of parent to be JPY 3,396 million.

The company provided year end dividend Guidance for the year ending September 30, 2019. For the period, the company expected year end dividend of JPY 15 per share compared to JPY 14 per share paid in the same period ago.